Aktuella utlysningar, vecka 41, 2020
Grants Office tipsar om aktuella utlysningar.
Svenska och nordiska utlysningar
French Swedish Research Day 2020
We are now opening the registration for the 23rd edition of the French Swedish Research Day on October 21st. This year’s theme is:
- Scientific Integrity and Ethics in research -
The event will take place at the Tekniska Museet in Stockholm.
We welcome one guest of honor:
- Jöel Eyer, scientific advisor at the French Office of Scientific Integrity ;
You are also welcome to present your work, in connection with this year’s theme (poster or short talk).
Everyone having an interest in French Swedish cooperation is welcome to join.
We hope that you will join us!
Date: October 21
Webinar: Combating COVID-19
A national SciLifeLab initiative funded by the Knut and Alice Wallenberg Foundation.
SciLifeLab is organizing a webinar on October 23 9:00-11:00, to highlight the exciting ongoing research and unique national team science approach in the SciLifeLab-KAW research program on COVID-19, aimed at exploring the major challenge that corona opposes to our society.
Just six months since KAW and SciLifeLab initiated the program, the very fast action and concerted efforts by the Swedish research community have generated several key findings, promoted by a collaborative, open science and data sharing strategy (read more about the SciLifeLab efforts against COVID-19 here). These efforts and achievements will be highlighted at the webinar.
vars ändamål är att stödja forskning som syftar till att förebygga, bota eller lindra diabetes hos barn och ungdomar utlyser minst 20 miljoner kr till forskning år 2020. Alla ansökningar som gäller typ 1-diabetes är välkomna, oavsett åldersgrupp. För vidare information och instruktioner hänvisas till hemsidan och till Barndiabetesfondens kansli. Kompletta ansökningar remitteras till Barndiabetesfondens vetenskapliga råd för bedömning. Beslut om och utdelning av anslag sker i december 2020.
Closing date: October 15, 2020
Africa – Initiation Grants for Internationalisation - STINT
Allt fler länder i världen erbjuder forskning och utbildning av god kvalitet. Denna utlysning avser mobilitetsmedel för utveckling av nya akademiska samarbeten med lärosäten i Afrika inom forskning och/eller högre utbildning.
Utlysningen avser projekt med upp till ett års varaktighet. Samarbetena ska vara balanserade med ömsesidig nytta och mobilitet i båda riktningar. Huvudsaklig samarbetspart ska vara i Afrika. Då det redan pågår flera aktiviteter för akademiska samarbeten med Sydafrika välkomnas särskilt ansökningar som avser samarbeten med andra länder i Afrika
Closing date: November 10, 2020
Anslag ur innovationsfonden - Stockholms läns landsting
Stöder utveckling av nya tjänster, processer, arbetssätt, produkter, metoder eller idéer inom alla verksamheter i Region Stockholm. Den totala budgeten uppgår till SEK 15 miljoner och maximalt belopp att söka vid ett tillfälle är SEK 1m kronor.
Closing date: 26 October 2020
Bertil Göranssons resestipendium för juniora alkoholforskare - Systembolaget
Delas ut till en ung forskare, som har gjort sig förtjänt därav genom framstående forskning inom området ungdom och alkohol. Stipendiet är värt SEK 30,000.
Closing date: 27 October 2020
Bidrag för forskningsrelaterade projekt - Astma och Allergiförbundet
Stöder olika forskningsrelaterade projekt bland annat för att arrangera vetenskapliga möten och föreläsningar inom allergiområdet samt för förstudier, examensarbete, initiativ till forskningsområden, artiklar, enkäter med mera.
Closing date: No specific deadline, applications can be submitted at any time.
COVID-19 research grant
The European Society of Human Reproduction and Embryology invites applications for its COVID-19 research grant. This supports research on the impact of SARS-CoV-2/COVID-10 on assisted reproductive technology. Two types of grants are available:
- impact of COVID-19 on patients or assisted reproductive technology, with up to €75,000;
- impact of SARS-CoV-2 on reproductive tissues, reproductive cells or assisted reproductive technology, worth up to €200,000.
Scientists and clinicians of any nationality who are members of the society are invited to apply.
Closing date: 15 October 2020
EACVI research grants
The European Society of Cardiology’s Cardiovascular Imaging Association (EACVI) invites applications for its research grants. These support research in the field of non-invasive imaging modalities in order to help young candidates obtain research experience in a high standard academic centre in an ESC member country other than their own.
Applicants must be silver members of the EACVI, under 40 years of age and residents in a European Society of Cardiology member country or affiliated member country. Applicants must be medical graduates at any stage in their career who have not yet obtained a permanent senior staff position or research experience above junior investigator level.
Grants are worth €30,000 over one year.
*** The closing date for this opportunity has been extended. The previous deadline of 30 September has been extended to 31 October. All other call details remain unchanged. ***
Closing date: 31 October 2020
EFSD/Lilly exploring and applying new strategies in diabetes expand programme
European Association for the Study of Diabetes invites applications for its EFDS/Lilly exploring and applying new strategies in diabetes expand programme. This supports diabetes research projects and potential strategies that can be implemented in Europe and rolled out in low- and middle income countries to favour the improvement of quality of care for people living with diabetes. Application within any area of clinical diabetes research may be submitted with emphasis on:
- prevention of diabetes, including lifestyle and educational interventions;
- diagnosis and management of all forms of diabetes mellitus;
- diagnosis and prevention of diabetes-related microvascular and macrovascular complications.
Single non-profit institutions or groups of such institutions from Europe and associated countries may apply. Applications in collaboration with development assistance committee member countries will also be considered.
Grants are generally worth €150,000 but larger grants can be awarded depending on funding requirements. Projects may last for one year or longer.
Closing date: 2 November 2020
The European and Developing Countries Clinical Trials Partnership invites nominations for their prizes. These recognise individuals and teams dedicated to the promotion of scientific research, improved health and Africa-European collaboration. The following awards are available:
- scientific leadership prize – worth €10,000 for an African scientist up to 50 years of age working on HIV/AIDS, tuberculosis, malaria and neglected infectious diseases;
- outstanding female scientist prize – worth €20,000 for a female scientist in sub-Saharan Africa;
- outstanding research team prize – worth €50,000 for a research team from Africa and Europe working on HIV/AIDS, tuberculosis, malaria and neglected infectious diseases.
- Dr Pascoal Mocumbi Prize – worth €50,000 to be awarded to senior scientists, policy-makers or advocates for health and research, from anywhere in the world.
Closing date: 29 October 2020
Federal Funding agencies
Notice of Special Interest (NOSI): Small Grants for Secondary Analyses of Existing Data Sets and Stored Biospecimens, NIH
Purpose: This Notice of Special Interest (NOSI) encourages applications that propose to conduct secondary analyses using publicly available Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)-funded data sets or stored biospecimens. The goal of this program is to facilitate innovative yet cost-effective research utilizing data and biospecimens collected with NICHD resources.
First available due date: October 16, 2020.
Expiration date: May 8, 2023.
Related Funding Opportunity Announcement (FOA): PA-20-200 (NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed).
Notice of Special Interest (NOSI) – Research on Rehabilitation Needs Associated with the COVID-19 Pandemic, NIH
Purpose: The purpose of this Notice of Special Interest is to encourage applications in three areas related to the intersection of COVID-19, the associated mitigation actions, and rehabilitation:
- Encourage research to address the rehabilitation needs of survivors of COVID-19
- Understand the impact of disruptions to rehabilitation services caused by the COVID-19 pandemic and associated mitigation actions
- Understand the social, behavioral, economic, and health impact of the COVID-19 pandemic and the associated mitigation actions on people with physical disabilities
Research applications addressing these topics are considered responsive; not all topics are expected within the same application. Applications will be directed to the National Center for Medical Rehabilitation Research (NCMRR) at Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
First available due date: February 5, 2021.
Expiration date: May 8, 2023.
Related Funding Opportunity Announcement (FOA): PA-20-185- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed), PA-18-480- NICHD Research Project Grant (Parent R01 Clinical Trial Required), PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed), PA-20-194 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
Understanding the Role of the M. Tuberculosis Granuloma in Tuberculosis (TB) Disease and Treatment Outcomes (R01 Clinical Trial Not Allowed), NIH
To support research to better define the role of the granuloma, the hallmark structure of pulmonary tuberculosis (TB), in TB disease and disease outcomes. Improved understanding of the granuloma will provide a much-needed knowledge base for the development of improved therapeutic approaches. This initiative will support in-depth studies in animal or ex vivo models and/or clinical studies to understand the role of M. tuberculosis (Mtb) granulomas in TB disease and treatment outcomes.
Closing date: February 22, 2021.
Funding Opportunity Announcement (FOA): RFA-AI-20-057
Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01, R21 Clinical Trial Not Allowed), NIH
This Funding Opportunity Announcement (FOA) invites research grant applications studying mechanisms of HIV-1 persistence in myeloid cells and strategies to target this reservoir in the central nervous system. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborations are encouraged but not required. High risk/high payoff projects that lack preliminary data may be most appropriate for the R21 mechanism, while applicants with preliminary data may wish to apply using the R01 mechanism.
Closing date: January 8, 2021. All applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-MH-20-701 (R01); RFA-MH-20-702 (R21).
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed), NIH
The purpose of this Funding Opportunity Announcement (FOA) is to address the needs of the maternal and pediatric HIV scientific community for research data translation and sharing.
This initiative will support secondary data analyses using archived HIV/AIDS data and specimens to generate new research questions and findings relevant to the scientific mission and priorities of the NICHD, Maternal and Pediatric Infectious Disease Branch (MPIDB), and Office of AIDS Research (OAR). The goal of this initiative is to encourage the scientific community to utilize HIV/AIDS archived data sets and specimen collections to answer important questions about the epidemiology, pathogenesis, treatment, clinical manifestations, and HIV-associated co-infections in maternal, pediatric and adolescent populations.
Closing date: December 10, 2020.
Funding Opportunity Announcement (FOA): RFA-HD-21-030
Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional), NIH
This Funding Opportunity Announcement (FOA) invites applications that apply a cross-disciplinary and team science approach to gain comprehensive mechanistic understanding of the impact of sex differences on the trajectories of brain aging, phenotypes, and risk of Alzheimer's Disease (AD) and AD-related dementia (ADRD), and on precision medicine for treatment and prevention of AD/ADRD, including the responsiveness to pharmacologic and non-pharmacologic interventions.
Closing date: November 10, 2020.
Funding Opportunity Announcement (FOA): RFA-AG-21-029
National Glaucoma Research Grant, BrightFocus Foundation, USA
BrightFocus provides research funds for U.S. and international researchers pursuing pioneering research leading to greater understanding, prevention, and treatment of glaucoma.
Standard Award Amount: $100,000 per year
Postdoctoral Fellowship Amount: $75,000 per year
Award durations: up to 2 years
Closing date: 10 November 2020, 5:00 PM EST (Full proposal).
Alzheimer's Disease Research Grant, BrightFocus Foundation, USA
The goal of the program is to accelerate our understanding of the biological mechanisms underlying Alzheimer’s Disease and related dementias as well as innovative approaches to better diagnose, prevent or delay the progress of the disease. Preference is made for exciting pilot projects that would not, at their present stage, be competitive for large government or industry awards. Typically, these awards are made to early stage investigators, or to more established investigators who are proposing particularly innovative research.
Amount: $100,000 per year
Award durations: Standard Awards can be up to 3 years. Fellowship Awards can be up to 2 years.
Eligibility: Fellowships are limited to researchers within 5 years of doctoral degree conferral (or end of residency). All other applicants are encouraged to apply for a standard award.
Closing date: 10 November 2020, 5:00 PM EST (Full proposal).
John and Elizabeth Leonard Family Foundation Basic Cancer Research Fellowship, AACR (American Association of Cancer Research), USA
The AACR-John and Elizabeth Leonard Family Foundation Basic Cancer Research Fellowship encourages and supports postdoctoral or clinical research fellows to establish a successful career path in cancer research. Research proposed for funding may be in any area of basic cancer research.
This fellowship provides a two-year grant of $120,000 to support the salary and benefits of the fellow while working on a mentored basic cancer research project. A partial amount of funds may be designated for non-personnel expenses, such as research/laboratory supplies, equipment, publication charges for manuscripts that pertain directly to the funded project, and other research expenses.
Closing date: 10/30/2020 1:00 PM (ET) (LOI); 02/05/2021 1:00 PM (ET) (Full proposal).
2020-2021 In-Cycle Grants, Alpha-1 Foundation, US
The Alpha-1 Foundation is committed to finding a cure for Alpha-1 Antitrypsin Deficiency and to improving the lives of individuals affected by Alpha-1 worldwide.
The Program supports basic science and clinical research, improved understanding of the pathogenesis of the clinical manifestations of AAT Deficiency, the development and testing of treatments for the disease, bioethics and social research, and the promotion of education of members of the medical community regarding AAT Deficiency.
- Bridge Grant (up to 1 year, and Up to $25,000)
- Pilot and Feasibility Grant (up to 1 year, and Up to $75,000)
- Postdoctoral Research Fellowship Grant (up to 2 year, and Up to $75,000/year)
- Research Grant (up to 2 years, Up to $100,000/year)
Closing date: Friday, November 13, 2020, 11:59pm ET (LOI); March 15, 2021, 11:59PM ET (Full proposal).